Akoya Biosciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKYA research report →
Companywww.akoyabio.com
Akoya Biosciences, Inc. , a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow.
- CEO
- Brian McKelligon
- IPO
- 2021
- Employees
- 205
- HQ
- Marlborough, MA, US
Price Chart
Valuation
- Market Cap
- $64.44M
- P/E
- -2.69
- P/S
- 1.70
- P/B
- -10.88
- EV/EBITDA
- -8.47
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.87%
- Op Margin
- -50.35%
- Net Margin
- -62.79%
- ROE
- -2796.13%
- ROIC
- -22.69%
Growth & Income
- Revenue
- $81.67M · -15.48%
- Net Income
- $-55,365,000 · 12.57%
- EPS
- $-1.12 · 21.68%
- Op Income
- $-46,730,000
- FCF YoY
- 14.65%
Performance & Tape
- 52W High
- $3.42
- 52W Low
- $0.93
- 50D MA
- $1.22
- 200D MA
- $2.04
- Beta
- 1.35
- Avg Volume
- 582.12K
Get TickerSpark's AI analysis on AKYA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 8, 25 | Mendel Scott | other | 56,322 |
| Jul 8, 25 | Mendel Scott | other | 50,000 |
| Jul 8, 25 | Mendel Scott | other | 44,959 |
| Jul 8, 25 | Mendel Scott | other | 35,562 |
| Jul 8, 25 | Mendel Scott | other | 30,549 |
| Jul 8, 25 | Mendel Scott | other | 28,500 |
| Jul 8, 25 | Ramachandran Niro Ph.D | other | 62,566 |
| Jul 8, 25 | Ramachandran Niro Ph.D | other | 42,148 |
| Jul 8, 25 | Ramachandran Niro Ph.D | other | 151,930 |
| Jul 8, 25 | Ramachandran Niro Ph.D | other | 130,625 |
Our AKYA Coverage
We haven't published any research on AKYA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AKYA Report →